Cartalax

Cartalax is a Cartilage Peptide Bioregulator supplied for laboratory research. Cartilage-derived bioregulator studied in vitro for chondrocyte activity pathway modeling, extracellular matrix synthesis signaling, and joint tissue mechanism research.

Cartalax (Ala-Glu-Asp) is a cartilage-tissue peptide bioregulator studied for chondrocyte activity and extracellular-matrix synthesis in joint-tissue research.

Cartalax is produced synthetically, not extracted from cartilage. Its tripeptide sequence (Ala-Glu-Asp) is based on a regulatory peptide associated with cartilage, and it is studied for chondrocyte and matrix signaling.

Cartalax is supplied as a lyophilized (freeze-dried) powder — a dehydrated form that keeps the peptide stable during shipping and storage. In the laboratory it is reconstituted (returned to liquid form) using a solvent such as bacteriostatic water, added slowly against the side of the vial, which is then swirled gently — never shaken — until the powder fully dissolves. All handling is for in vitro research use only.

Store the lyophilized Cartalax powder at -20°C, protected from light and moisture, where it remains stable long-term. Once reconstituted, keep it refrigerated (2-8°C) and use it within the timeframe appropriate for your research protocol.

Every batch of Cartalax is produced to a purity of 99% or higher. Purity and molecular identity are verified using standard analytical methods — high-performance liquid chromatography (HPLC) to measure purity, and mass spectrometry (MS) to confirm the peptide's molecular weight.